265 related articles for article (PubMed ID: 32156728)
1. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation.
Raffeiner P; Hart JR; García-Caballero D; Bar-Peled L; Weinberg MS; Vogt PK
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6571-6579. PubMed ID: 32156728
[TBL] [Abstract][Full Text] [Related]
2. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
3. Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
Si J; Yu X; Zhang Y; DeWille JW
Mol Cancer; 2010 Apr; 9():92. PubMed ID: 20426839
[TBL] [Abstract][Full Text] [Related]
4. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
Chang H; Zhang X; Li B; Meng X
Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
[TBL] [Abstract][Full Text] [Related]
5. The MYCL and MXD1 transcription factors regulate the fitness of murine dendritic cells.
Anderson DA; Murphy TL; Eisenman RN; Murphy KM
Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4885-4893. PubMed ID: 32071205
[TBL] [Abstract][Full Text] [Related]
6. An efficient KRAB domain for CRISPRi applications in human cells.
Alerasool N; Segal D; Lee H; Taipale M
Nat Methods; 2020 Nov; 17(11):1093-1096. PubMed ID: 33020655
[TBL] [Abstract][Full Text] [Related]
7. The MNT transcription factor autoregulates its expression and supports proliferation in MYC-associated factor X (MAX)-deficient cells.
Lafita-Navarro MC; Liaño-Pons J; Quintanilla A; Varela I; Blanco R; Ourique F; Bretones G; Aresti J; Molina E; Carroll P; Hurlin P; Romero OA; Sanchez-Céspedes M; Eisenman RN; Delgado MD; León J
J Biol Chem; 2020 Feb; 295(7):2001-2017. PubMed ID: 31919096
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Myc transcriptional activity by a mini-protein based upon Mxd1.
Demma MJ; Hohn MJ; Sun A; Mapelli C; Hall B; Walji A; O'Neil J
FEBS Lett; 2020 May; 594(10):1467-1476. PubMed ID: 32053209
[TBL] [Abstract][Full Text] [Related]
9. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes.
Wahlström T; Belikov S; Arsenian Henriksson M
Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma.
Wong LS; Wei L; Wang G; Law CT; Tsang FH; Chin WC; Ng IO; Wong CM
Cell Mol Gastroenterol Hepatol; 2022; 14(5):1053-1076. PubMed ID: 35944892
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription.
Struntz NB; Chen A; Deutzmann A; Wilson RM; Stefan E; Evans HL; Ramirez MA; Liang T; Caballero F; Wildschut MHE; Neel DV; Freeman DB; Pop MS; McConkey M; Muller S; Curtin BH; Tseng H; Frombach KR; Butty VL; Levine SS; Feau C; Elmiligy S; Hong JA; Lewis TA; Vetere A; Clemons PA; Malstrom SE; Ebert BL; Lin CY; Felsher DW; Koehler AN
Cell Chem Biol; 2019 May; 26(5):711-723.e14. PubMed ID: 30880155
[TBL] [Abstract][Full Text] [Related]
12. Mnt transcriptional repressor is functionally regulated during cell cycle progression.
Popov N; Wahlström T; Hurlin PJ; Henriksson M
Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876
[TBL] [Abstract][Full Text] [Related]
13. Role for carbohydrate response element-binding protein (ChREBP) in high glucose-mediated repression of long noncoding RNA Tug1.
Long J; Galvan DL; Mise K; Kanwar YS; Li L; Poungavrin N; Overbeek PA; Chang BH; Danesh FR
J Biol Chem; 2020 Nov; 295(47):15840-15852. PubMed ID: 32467232
[TBL] [Abstract][Full Text] [Related]
14. BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.
Sharma N; Magistroni V; Piazza R; Citterio S; Mezzatesta C; Khandelwal P; Pirola A; Gambacorti-Passerini C
Mol Cancer; 2015 Jul; 14():132. PubMed ID: 26179066
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor as a master regulator of the c-MYC/MXD1 network.
Salehi-Tabar R; Nguyen-Yamamoto L; Tavera-Mendoza LE; Quail T; Dimitrov V; An BS; Glass L; Goltzman D; White JH
Proc Natl Acad Sci U S A; 2012 Nov; 109(46):18827-32. PubMed ID: 23112173
[TBL] [Abstract][Full Text] [Related]
16. Structural aspects of interactions within the Myc/Max/Mad network.
Nair SK; Burley SK
Curr Top Microbiol Immunol; 2006; 302():123-43. PubMed ID: 16620027
[TBL] [Abstract][Full Text] [Related]
17. The activities of MYC, MNT and the MAX-interactome in lymphocyte proliferation and oncogenesis.
Link JM; Hurlin PJ
Biochim Biophys Acta; 2015 May; 1849(5):554-62. PubMed ID: 24731854
[TBL] [Abstract][Full Text] [Related]
18. MXD1 localizes in the nucleolus, binds UBF and impairs rRNA synthesis.
Lafita-Navarro MC; Blanco R; Mata-Garrido J; Liaño-Pons J; Tapia O; García-Gutiérrez L; García-Alegría E; Berciano MT; Lafarga M; León J
Oncotarget; 2016 Oct; 7(43):69536-69548. PubMed ID: 27588501
[TBL] [Abstract][Full Text] [Related]
19. Dynamic in vivo interactions among Myc network members.
Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
[TBL] [Abstract][Full Text] [Related]
20. Mad proteins contain a dominant transcription repression domain.
Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]